Dr. Cortes on Better Understanding Areas of Interest in ALL
February 24th 2023Jorge E. Cortes, MD, discusses important questions in acute lymphoblastic leukemia to address, such as improved understanding of the role of allogenic stem cell transplant and the use of tyrosine kinase inhibitor combinations.
Read More
Dr. Cortes on the Results of Quizartinib in Relapsed/Refractory AML
June 16th 2018Jorge E. Cortes, MD, professor and deputy chair, Department of Leukemia, The University of Texas MD Anderson Cancer Center, discusses the results of quizartinib in patients with relapsed/refractory acute myeloid leukemia.
Read More